The over-expression of the proto-oncogene HER-2 (c-erbB-2/ neu) in ovarian, endometrial and mammary carcinoma is an important indicator for poor prognosis. We have previously shown in 3 out of 4 ovarian carcinoma cell lines an interferongamma (IFN-+mediated reduction in HER-2 specific protein and RN
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells
✍ Scribed by Christian Marth; Andreas Dreps; Clara Natoli; Alain G. Zeimet; Thomas Lang; Martin Widschwendter; Günter Daxenbichler; Axel Ullrich; Stefano Iacobelli
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 642 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The spontaneous expression of HLA class‐I and class‐II molecules in 5 human breast carcinoma cell lines, MCF‐7, T47D, ZR75‐I, HSL‐53, MDA‐MB 231, and their modulation during IFN‐~γ~ treatment, are reported. The expression of cell‐surface determinants was examined by indirect immunofluor
In mammals, transforming growth factor-beta (TGF-beta) is found in 3 highly homologous isoforms that exert their effects via heteromeric complexes of type-I and type-II receptors (TbetaR-I and TbetaR-II). TGF-beta regulates the growth and metabolism of various cell types, including keratinocytes. We